Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1981-06-12 (44 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CREYSSE (24100), Dordogne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES 3 VALLEES : revenue, balance sheet and financial ratios
PHARMACIE DES 3 VALLEES is a French company
founded 44 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CREYSSE (24100),
this company of category PME
shows in 2022 a revenue of 3.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES 3 VALLEES (SIREN 322007725)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
3 049 799 €
N/C
N/C
N/C
N/C
N/C
Net income
130 761 €
174 951 €
210 070 €
273 861 €
177 205 €
80 659 €
-35 640 €
-41 321 €
EBITDA
N/C
N/C
281 631 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.9%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DES 3 VALLEES generates positive net income of 131 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
130 761 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 481%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
481.064%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
12.008%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES 3 VALLEES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
124.667
135.668
166.247
54.926
33.354
61.937
335.906
481.064
Financial autonomy
23.938
20.918
23.897
33.702
43.251
22.172
17.366
12.008
Repayment capacity
None
None
None
None
None
0.804
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
7.089%
None%
None%
Sector positioning
Debt ratio
481.062024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+31 pts over 3 years
In 2024, the debt ratio of PHARMACIE DES 3 VALLEES (481.06) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
12.01%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of PHARMACIE DES 3 VALLEES (12.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
0.8 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE DES 3 VALLEES (0.80) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 187.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
187.771
Liquidity indicators evolution PHARMACIE DES 3 VALLEES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
88.819
86.764
181.357
150.869
176.997
112.079
307.828
187.771
Interest coverage
None
None
None
None
None
1.125
None
None
Sector positioning
Liquidity ratio
187.772024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+32 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DES 3 VALLEES (187.77) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.12x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE DES 3 VALLEES (1.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES 3 VALLEES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
41 660 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
48
0
0
Customer payment term (days)
0
0
0
0
0
6
0
0
Supplier payment term (days)
0
0
0
0
0
49
0
0
Positioning of PHARMACIE DES 3 VALLEES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES 3 VALLEES is estimated at
1 825 520 €
(range 1 271 263€ - 2 731 082€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1271k€1825k€2731k€
1 825 520 €Range: 1 271 263€ - 2 731 082€
NAF 5 année 2024
Valuation method used
Net Income Multiple
130 761 €
×
14.0x
=1 825 520 €
Range: 1 271 263€ - 2 731 083€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES 3 VALLEES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES 3 VALLEES
What is the revenue of PHARMACIE DES 3 VALLEES ?
The revenue of PHARMACIE DES 3 VALLEES in 2022 is 3.0 M€.
Is PHARMACIE DES 3 VALLEES profitable?
Yes, PHARMACIE DES 3 VALLEES generated a net profit of 131 k€ in 2024.
Where is the headquarters of PHARMACIE DES 3 VALLEES ?
The headquarters of PHARMACIE DES 3 VALLEES is located in CREYSSE (24100), in the department Dordogne.
Where to find the tax return of PHARMACIE DES 3 VALLEES ?
The tax return of PHARMACIE DES 3 VALLEES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES 3 VALLEES operate?
PHARMACIE DES 3 VALLEES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart